The Hyderabad-based vaccine maker conducted phase 2 trials on 650 volunteers
The COVID-19 vaccines can be "tweaked" to provide protection against new variants of the virus, All India Institute of Medical Sciences (AIIMS), Delhi, Director Dr Randeep Guleria said. His remarks come amid rising cases of the Omicron variant of coronavirus and the ongoing debate about whether a booster shot is needed to increase antibodies. Speaking at a programme organised here in Maharashtra on Sunday, Dr Guleria said that as far as the severity of the Omicron variant is concerned, the next few weeks will be very crucial. "Although there is this new variant of COVID-19, the silver lining is that it does seem to be a milder disease and we should have protection as far as the vaccine is concerned. And I think it is important to remember that vaccines can be tweaked," Dr Guleria here said on Sunday. "We will have second-generation vaccines. This is something which we need to keep in mind. The current vaccines are effective but with new variants, they will decrease on immunity, ...
The cumulative number of COVID-19 vaccine doses administered in the country has crossed 134.53 crore on Tuesday, the Union Health Ministry said.
Compulsory vaccination against Covid-19 has become mandatory in Puducherry from Sunday, Lt Governor Tamilsai Soundararajan said.
The countrywide vaccination drive was rolled out on January 16
Specific cluster outbreaks of Covid-19 in various parts of the country are also being investigated, INSACOG said
Of the 36 states and Union Territories for which vaccination data is available, 20 states recorded a rise in vaccination growth during the last week.
The cumulative number of Covid vaccine doses administered in the country crossed 125 crore on Wednesday, the Union Health Ministry said.
The National Technical Advisory Group on Immunisation is working on a comprehensive policy on a booster shot and additional doses in the next two weeks
The country launched vaccination for all people aged more than 45 years from April 1
The next phase of Covid-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified comorbid conditions
Bharat Biotech made 55 million doses of Covaxin in October, and aims to make 80 million doses in December.
India must speed up vaccination
JAB AT HAND: From encouraging people to volunteer to screening kids and winning their confidence
Warns that a new crisis can come; asks officials to take religious leaders' help in tackling rumours
BCG pointed out that across India only 54-62 per cent is willing to take the second dose
Most populous states may decide pace going forward
'We are delivering 220 million doses a month, and almost everything is being consumed', said Poonawalla
Nearly half of all employees leave vaccine transparency in the hands of their employers
India will soon create history by achieving the target of vaccinating over 1 billion people against Covid-19, Union Minister of State for Health Bharati Pawar said here on Tuesday